Dan advises healthcare provider clients in connection with a variety of legal and operational challenges, blending a business-centric approach to healthcare with regulatory considerations, including compliance with the 340B Drug Pricing Program, vendor and payor contract negotiations, provider-based conversion assessments and compliance, reimbursement strategies, mergers and acquisitions, and establishing value-based care models.